Recombinant human serum albumin-therapeutic drug conjugate
AssigneeWuhan Healthgen Biotechnology Corp
InventorsLiangliang DONG, Daichang YANG, Jun XIA, Rong CHEN, Chuan SHI
Life of this patent
Estimating the term…
Loading patent…
AssigneeWuhan Healthgen Biotechnology Corp
InventorsLiangliang DONG, Daichang YANG, Jun XIA, Rong CHEN, Chuan SHI
Estimating the term…
The present invention relates to a drug conjugate of recombinant human serum albumin and a therapeutic drug. The drug conjugate is formed by covalent coupling a therapeutic drug to a free sulfhydryl group at position 34 of recombinant human serum albumin via a heterobifunctional linker. The drug conjugate of the present invention not only enhances the pharmacological action and improves the pharmacokinetics of the therapeutic drug, but also significantly increases the coupling efficiency of the therapeutic drug to human serum albumin, thereby reducing the production cost of the drug conjugate.
A drug-linker-albumin conjugate comprising:
Dependencies are inferred from the claim text.